Mahogany Fund Management

Mahogany focuses on buyouts, growth equity, management buy-ins, management buyouts, and pre-IPO placements in the Australian lower mid-market. The firm targets founder-owned businesses, family enterprises, and corporate divestitures, typically in transactions between A$10 million and A$50 million in enterprise value.

Mahogany has demonstrated a capability for public-to-private transactions. The firm participated in the 2023 take-private of ASX-listed Capitol Health as part of a consortium that included Adamantem Capital, reflecting an opportunistic willingness to access deals through listed markets when an appropriate private equity thesis exists.

Mahogany sources opportunities through proprietary relationships with business owners, corporate advisors, and professional services firms in Melbourne and broader Australia. The firm's succession-transaction focus provides a differentiated origination channel: retiring founders often approach private equity firms directly when no internal successor exists, creating off-market deal flow.

Mahogany has not publicly disclosed standard holding periods or fund terms. As a lower-mid-market firm pursuing control-oriented transactions, typical holding periods for firms of this profile in Australia range from four to seven years, with value creation driven by operational improvement, strategic acquisitions, and professionalization of founder-led businesses.

Yes. Mahogany co-invests alongside other private equity general partners in Australia and New Zealand, consistent with a firm profile that operates committed fund vehicles and seeks to share underwriting and governance on larger or more complex transactions.